secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2022-10-17T23:59:59+00:00
Accession:  0001104659-22-109061
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie Vice Chairman & CLO Laura Schumacher to retire; Perry Siatis named General Counsel
--------------------------------------------------------------------------------

- Laura J. Schumacher, Vice Chairman & Chief Legal Officer, to retire after 32-year career at AbbVie and Abbott.
- Perry C. Siatis, currently SVP & Deputy General Counsel, will succeed her as EVP, General Counsel & Secretary.
- Schumacher led creation of AbbVie's legal function, oversaw $63B Allergan acquisition, and established AbbVie Foundation.
- Siatis joined Abbott legal in 2005, advanced through leadership roles, served as chief compliance officer.
- Transition is effective after a period; Schumacher will remain in advisory role during transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922109061/0001104659-22-109061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922109061/tm2228315d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-109061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer